HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antimicrobial activities of ozenoxacin against isolates of propionibacteria and staphylococci from Japanese patients with acne vulgaris.

Abstract
Ozenoxacin, a novel non-fluorinated topical quinolone, was assessed for in vitro antimicrobial activity against clinical isolates of propionibacteria and staphylococci according to the broth microdilution method recommended by the Clinical and Laboratory Standards Institute. The isolates used in this study were collected from Japanese patients with acne vulgaris during a period from 2012 to 2013. The MIC90s of ozenoxacin against Propionibacterium acnes (n=266), Propionibacterium granulosum (n=10), Staphylococcus aureus (n=23), Staphylococcus epidermidis (n=229) and other coagulase-negative staphylococci (n=82) were ≤0.06, ≤0.06, ≤0.06, 0.125 and ≤0.06 µg ml-1, respectively. The antimicrobial activity of ozenoxacin against the clinical isolates of propionibacteria and staphylococci was greater than that of five reference antimicrobial agents which have been used for the treatment of acne vulgaris. The MICs of ozenoxacin were correlated with those of nadifloxacin in P. acnes and S. epidermidis isolates. However, the MICs of ozenoxacin were 0.25-0.5 µg ml-1 and 0.5-8 µg ml-1 against nadifloxacin-resistant P. acnes (MIC: ≥8 µg ml-1; n=8) and S. epidermidis (MIC: ≥64 µg ml-1; n=10), respectively. These results indicated the potent antimicrobial activity against P. acnes and S. epidermidis isolates resistant to nadifloxacin. Topical ozenoxacin could represent an alternative therapeutic drug for acne vulgaris based on its potent antimicrobial activity against the isolates of propionibacteria and staphylococci from acne patients.
AuthorsAkiko Nakajima, Fumiaki Ikeda, Shoji Kanayama, Kazuaki Okamoto, Tatsumi Matsumoto, Ritsuko Ishii, Akira Fujikawa, Katsuaki Takei, Makoto Kawashima
JournalJournal of medical microbiology (J Med Microbiol) Vol. 65 Issue 8 Pg. 745-750 (Aug 2016) ISSN: 1473-5644 [Electronic] England
PMID27305898 (Publication Type: Journal Article)
Chemical References
  • Aminopyridines
  • Anti-Infective Agents
  • Fluoroquinolones
  • Quinolizines
  • Quinolones
  • nadifloxacin
  • ozenoxacin
Topics
  • Acne Vulgaris (microbiology)
  • Aminopyridines (pharmacology)
  • Anti-Infective Agents (pharmacology)
  • Asian People
  • Fluoroquinolones (pharmacology)
  • Humans
  • Microbial Sensitivity Tests
  • Propionibacterium (drug effects, isolation & purification)
  • Quinolizines (pharmacology)
  • Quinolones (pharmacology)
  • Staphylococcus (drug effects, isolation & purification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: